Loading organizations...
§ Private Profile · Mahwah, NJ, USA
advertising agency specializing in storytelling and digital engagement. They create compelling narratives and interactive digital experiences.
Fusion is an advertising agency operating from an undisclosed location that specializes in corporate storytelling and digital engagement strategies. The firm focuses on creating compelling narratives and interactive digital experiences designed to connect corporate brands with their target audiences across various media channels. Financial and operational metrics, including total funding raised, current enterprise valuation, and the exact employee headcount, are not publicly disclosed at this time. Furthermore, the agency maintains strict confidentiality regarding its commercial relationships, meaning specific recognizable names of lead investors, strategic partners, or flagship enterprise customers remain completely unavailable. Specific details regarding their underlying business model, core industry sectors served, and proprietary technological capabilities have not yet been released to the broader commercial market. The organization's exact founding year and the identities of its original founders are currently unverified in public corporate records.
Fusion has raised $105.0M across 1 funding round.
Fusion has raised $105.0M in total across 1 funding round.
Fusion has raised $105.0M across 1 funding round. Most recently, it raised $105.0M Series B in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 2, 2019 | $105M Series B | Chau Khuong, Deepak Khuntia | Adams Street Partners, Facit, Genesys Capital, HealthCap, Johnson & Johnson Innovation, Perceptive Advisors, Heather Preston, Rock Springs Capital, Alan O'connell, TPG Biotech | Announced |
Fusion has raised $105.0M in total across 1 funding round.
Fusion's investors include Chau Khuong, Deepak Khuntia, Adams Street Partners, FACIT, Genesys Capital, HealthCap, Johnson & Johnson Innovation, Perceptive Advisors, Heather Preston, Rock Springs Capital, Alan O'Connell, TPG Biotech.